Skip to main content
. 2014 Sep;58(9):5306–5314. doi: 10.1128/AAC.02574-14

TABLE 1.

Characteristics of tested strains

Strain Origin Resistance agr type/CCa Associated resistances VAN MIC (mg/liter) Growth on BHI agar with 4 mg/liter VAN AUC/Mu3 AUC (%)
FOU Isolated from patient with cystic fibrosis MRSA, mecA positive II/CC5 Kanamycin, tobramycin, erythromycin, lincomycin, fusidic acid, rifampin 1.5 No 51
NAR Isolated from patient with cystic fibrosis MRSA, mecA positive I/CC8 Kanamycin, tobramycin, levofloxacin 1.5 No 41
GUA Isolated from patient with cystic fibrosis MRSA, mecA positive II/CC5 Kanamycin, tobramycin, fusidic acid 2 No 58
a

CC, clonal complex, determined from DNA microarray.